MicroRNA-34c is associated with emphysema severity and modulates SERPINE1 expression

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Savarimuthu Francis, Santiyagu M ^a,b   Davidson, Morgan R ^a,b   Tan, Maxine E ^b   Wright, Casey M ^a,b   Clarke, Belinda E ^a   Duhig, Edwina E ^a   Bowman, Rayleen V ^a,b   Hayward, Nicholas K ^b,c   Fong, Kwun M ^a,b   Yang, Ian A ^a,b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Microarray; microRNA; miR 34c

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 133A; MICRORNA 133B; MICRORNA 149; MICRORNA 34B; MICRORNA 34C; PLASMINOGEN ACTIVATOR INHIBITOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ALDOA GENE; ARTICLE; CELL STRAIN BEAS 2B; CELL STRAIN HFL1; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EMPHYSEMA; EX VIVO STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GAS DIFFUSION; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HNF4A GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG CANCER; LUNG PARENCHYMA; MALE; MAP4K4 GENE; MICROARRAY ANALYSIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; RNA ISOLATION; SERPINE1 GENE; ZNF3 GENE;

AGED; CELL LINE; CELL LINE, TUMOR; DOWN-REGULATION; EMPHYSEMA; FEMALE; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LUNG; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TRANSFECTION; UP-REGULATION;

EID: 84896713202     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-88     Document Type: Article

References (43)

1. Chen XM, Splinter PL, O'Hara SP, LaRusso NF. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 2007, 282(39):28929-28938. 10.1074/jbc.M702633200, 2194650, 17660297.
2. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9(3):189-198. 10.1016/j.ccr.2006.01.025, 16530703.
3. Lin PY, Yu SL, Yang PC. MicroRNA in lung cancer. Br J Cancer 2010, 103(8):1144-1148. 10.1038/sj.bjc.6605901, 2967070, 20859290.
4. Blenkiron C, Goldstein LD, Thorne NP, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 2007, 8(10):R214. 10.1186/gb-2007-8-10-r214, 2246288, 17922911.
5. Heneghan HM, Miller N, Kerin MJ. MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol 2010, 10(5):543-550. 10.1016/j.coph.2010.05.010, 20541466.
6. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007, 104(5):1604-1609. 10.1073/pnas.0610731104, 1780072, 17242365.
7. Sonkoly E, Pivarcsi A. microRNAs in inflammation. Int Rev Immunol 2009, 28(6):535-561. 10.3109/08830180903208303, 19954362.
8. Mann DL. MicroRNAs and the failing heart. N Engl J Med 2007, 356(25):2644-2645. 10.1056/NEJMcibr072068, 17582077.
9. Sheedy FJ, O'Neill LA. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008, 67(Suppl 3):iii50-iii55.
10. Oglesby IK, McElvaney NG, Greene CM. MicroRNAs in inflammatory lung disease-master regulators or target practice?. Respir Res 2010, 11:148. 10.1186/1465-9921-11-148, 2984500, 21029443.
11. Jiang X. The emerging role of microRNAs in asthma. Mol Cell Biochem 2011, 353(1-2):35-40. 10.1007/s11010-011-0771-z, 21380724.
12. Pandit KV, Corcoran D, Yousef H, et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010, 182(2):220-9. 10.1164/rccm.200911-1698OC, 2913236, 20395557.
13. Oglesby IK, Bray IM, Chotirmall SH, et al. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol 2010, 184(4):1702-9. 10.4049/jimmunol.0902669, 20083669.
14. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349(9064):1498-504. 10.1016/S0140-6736(96)07492-2, 9167458.
15. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998, 4(11):1241-3. 10.1038/3218, 9809543.
16. Yang IA, Francis SM. Deconstructing COPD using genomic tools. Respirology 2009, 14(3):313-7.
17. Scanlon PD. The pathogenesis and pathology of COPD: identifying risk factors and improving morbidity and mortality. Adv Stud Med 2004, 4(10A):S744-S749.
18. Savarimuthu Francis SM, Larsen JE, Pavey SJ, et al. Expression profiling identifies genes involved in emphysema severity. Respir Res 2009, 10(1):81. 10.1186/1465-9921-10-81, 2746189, 19723343.
19. Spira A, Beane J, Pinto-Plata V, et al. Gene expression profiling of human lung tissue from smokers with severe emphysema. AJRCMB 2004, 31(6):601-10.
20. Ning W, Li CJ, Kaminski N, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A 2004, 101(41):14895-900. 10.1073/pnas.0401168101, 522001, 15469929.
21. Wang IM, Stepaniants S, Boie Y, et al. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 2008, 177(4):402-11. 10.1164/rccm.200703-390OC, 17975202.
22. Bhattacharya S, Srisuma S, Demeo DL, et al. Molecular biomarkers for quantitative and discrete COPD phenotypes. AJRCMB 2009, 40(3):359-67. 2645534, 18849563.
23. Savarimuthu Francis SM, Larsen JE, Pavey SJ, et al. Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD. PLoS ONE 2011, 6(3):e17442. 10.1371/journal.pone.0017442, 3057973, 21423603.
24. Van Pottelberge GR, Mestdagh P, Bracke KR, et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011, 183(7):898-906. 10.1164/rccm.201002-0304OC, 21037022.
25. Ezzie ME, Crawford M, Cho JH, et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 2012, 67(2):122-31. 10.1136/thoraxjnl-2011-200089, 21940491.
26. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3(7):RESEARCH0034. 126239, 12184808.
27. Zeskind JE, Lenburg ME, Spira A. Translating the COPD Transcriptome: Insights into Pathogenesis and Tools for Clinical Management. Proc Am Thorac Soc 2008, 5(8):834-41. 10.1513/pats.200807-074TH, 2645236, 19017738.
28. Chen ZH, Kim HP, Sciurba FC, et al. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 2008, 3(10):e3316. 10.1371/journal.pone.0003316, 2552992, 18830406.
29. Carnevali S, Petruzzelli S, Longoni B, et al. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2003, 284(6):L955-63.
30. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005, 33(4):1290-7. 10.1093/nar/gki200, 552951, 15741182.
31. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005, 102(39):13944-9. 10.1073/pnas.0506654102, 1236577, 16166262.
32. Babar IA, Slack FJ, Weidhaas JB. miRNA modulation of the cellular stress response. Future Oncol 2008, 4(2):289-98. 10.2217/14796694.4.2.289, 18407740.
33. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008, 455(7209):64-71. 10.1038/nature07242, 2745094, 18668037.
34. Bouhallier F, Allioli N, Lavial F, et al. Role of miR-34c microRNA in the late steps of spermatogenesis. Rna 2010, 16(4):720-31. 10.1261/rna.1963810, 2844620, 20150330.
35. Wang Z, Bishop EP, Burke PA. Expression profile analysis of the inflammatory response regulated by hepatocyte nuclear factor 4alpha. BMC Genomics 2011, 12:128. 10.1186/1471-2164-12-128, 3053261, 21352552.
36. Hu H, Zhao Y, Xiao Y, Zhang R, Song H. Disruption of plasminogen activator inhibitor-1 gene enhances spontaneous enlargement of mouse airspace with increasing age. Tohoku J Exp Med 2010, 222(4):291-6. 10.1620/tjem.222.291, 21139380.
37. Muth M, Theophile K, Hussein K, Jacobi C, Kreipe H, Bock O. Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression. J Transl Med 2010, 8:33. 10.1186/1479-5876-8-33, 2853517, 20356416.
38. Xu X, Wang H, Wang Z, Xiao W. Plasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cells. Exp Lung Res 2009, 35(9):795-805. 10.3109/01902140902912519, 19916862.
39. To M, Takagi D, Akashi K, et al. Sputum plasminogen activator inhibitor-1 elevation by oxidative stress-dependent nuclear factor-kappaB activation in COPD. Chest 2013, 144(2):515-21. 10.1378/chest.12-2381, 23558707.
40. Jiang Y, Xiao W, Zhang Y, Xing Y. Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease. Respirology 2010, 15(6):939-46. 10.1111/j.1440-1843.2010.01799.x, 20624254.
41. Chiba Y, Misawa M. MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hyperresponsiveness in asthma. J Pharmacol Sci 2010, 114(3):264-8. 10.1254/jphs.10R10FM, 20953121.
42. Sanchez-Simon FM, Zhang XX, Loh HH, Law PY, Rodriguez RE. Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol Pharmacol 2010, 78(5):935-42. 10.1124/mol.110.066837, 2981367, 20716624.
43. Novak G, LeBlanc M, Zai C, et al. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann Hum Genet 2010, 74(4):291-8. 10.1111/j.1469-1809.2010.00578.x, 20456319.